For decades, circular RNAs (circRNAs) were dismissed as "splicing noise"—accidental byproducts of the cellular machinery. However, a growing body of research reveals that these covalently closed loops are sophisticated regulators of gene expression. Unlike linear mRNA, circRNAs lack free ends, making them highly resistant to degradation by exonucleases. This stability allows them to persist in the cytoplasm and function as "molecular sponges" that sequester microRNAs (miRNAs), effectively acting as a competitive endogenous RNA (ceRNA) network.
The Mechanism of Molecular Sponging
The most prevalent mechanism identified across these studies is the ability of circRNAs to act as decoys. In a healthy cell, miRNAs typically bind to the 3' untranslated regions (UTRs) of target messenger RNAs (mRNAs), leading to their degradation or translational repression. A circRNA "sponge" disrupts this process by harboring multiple binding sites for specific miRNAs.
As Xiaying Zheng, Rong Jiang, and colleagues demonstrated in The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer, the circRNA circSEPT9 sequesters tumor-suppressing miRNAs. By "soaking up" these miRNAs, the circRNA prevents them from silencing their intended oncogenic targets, thereby facilitating cancer progression. This competitive inhibition effectively releases the "brakes" on gene expression, allowing downstream proteins to be overexpressed.
The circRNA-miRNA-mRNA Axis
This regulatory logic is often framed as a three-part "axis." By identifying these axes, researchers can map the specific pathways driving disease. For instance, Jia Li and Gang Zhang identified the circSFMBT2/miR-665 axis in gastric cancer, where the circRNA neutralizes a microRNA that would otherwise suppress tumor growth.
Similar patterns appear across diverse pathologies:
- Vascular Health: Yan Sun and Weiwei Hao showed that circErbB4 sponges miR-29a-5p to promote the migration of vascular smooth muscle cells.
- Acute Injury: In sepsis-induced lung injury, Mei-Jia Shen and Wen Li found that hsa_circ_0003091 sponges the miR-149/Smad2 axis, driving inflammation.
- Hematology: Kun Wu and Bo Nie identified a circuit where the transcription factor MEF2A drives circPVT1, which then sponges miRNAs to protect pro-survival proteins in leukemia.
Beyond Sponging: Scaffolds and Decoys
While sponging is the dominant theme, circRNAs also function through direct protein interaction. They can act as protein scaffolds, bringing multiple molecules together to facilitate a reaction, or as protein decoys, sequestering RNA-binding proteins away from their targets.
In the context of diabetic retinopathy, Xiao‐Lin Fu and Jianzhi Chen discovered that circZNF532 recruits the protein TAF15 to stabilize specific mRNA transcripts. This mechanism bypasses the miRNA sponge entirely, instead using the circRNA as a physical bridge to ensure the continued translation of harmful proteins. Similarly, Danyang Chen and Pan Li found that circ-FOXO3 interacts with the epigenetic regulator WHSC1, sequestering it in the cytoplasm to prevent the activation of metastatic genes in the nucleus.
Clinical Utility as Biomarkers and Targets
The structural stability of circRNAs makes them ideal candidates for "liquid biopsies." Because they are resistant to the enzymes that typically break down RNA in the bloodstream, they can be reliably detected in serum and exosomes.
Chang Fu Tian and Min Zhao highlighted exosomal circRNAs as potential biomarkers for sepsis, noting their high diagnostic stability. Furthermore, because these molecules often drive drug resistance—such as circEPSTI1 promoting cisplatin resistance in cervical cancer as shown by Jing Qin and Jiayu Zhu—silencing these circular loops offers a path toward restoring chemotherapy sensitivity.
By viewing circRNAs not as errors, but as a hidden layer of the cell's regulatory architecture, researchers are uncovering a universal mechanism of gene control that spans from rice immunity to human heart regeneration.